Stopping Beta-Blockers After Heart Attack Safe for Stable Patients, Korea-France Study Finds
One medication many patients take long-term following a heart attack is a beta-blocker. The drug slows the heart rate and reduces the force of...
Search results for "Europe"
Zymfentra U.S. Sales Surge 176% as Celltrion’s Remsima Franchise Eyes 1 Trillion Won Annual Revenue
Biopharmaceutical company Celltrion announced on Aug. 27 that combined first-half sales of its subcutaneous infliximab products—Remsima SC and...
Single Abdominal Ultrasound Can Gauge Liver Cancer Risk in Fatty Liver Patients, Study Finds
Fatty liver disease is one of the most common findings during routine health screenings.
Bizarre Preseason Accident: Juventus Defender Federico Gatti Hurt in Pitch Invasion
A bizarre injury unfolded in Italian football as national-team defender Federico Gatti, 28, was sidelined after an...
Same Arthritis Drug, Different Results: Why Treatment Nonresponse Is Not Your Fault
If two patients take the exact same medication, why does one recover while the other sees little to no improvement.
Celltrion Files for South Korean Approval of Keytruda Biosimilar CT-P51
Celltrion announced on August 24 that it has submitted a marketing authorization application to South Korea’s Ministry...
Jeon Somi Stuns in Micro Shorts: Inside Her Core-Strengthening Pilates Routine
Singer Jeon Somi turned heads with a bold stage outfit during a recent performance in Europe.
Hanmi Pharmaceutical’s Paltan Smart Plant Cuts Drug Stockouts 57% Following Reorganization
Stockout cases have dropped sharply at Hanmi Pharmaceutical’s primary manufacturing base for synthetic drugs.
Letting Go of the Wheel: Finding Clarity, Culture, and Coastal Charm in Amalfi
“The Amalfi Coast road is winding and congested, making it difficult to drive unless you are exceptionally skilled.
When Both Partners Face Cancer: How Shared Diets and Lifestyles Shape Risk
"My spouse and I became cancer patients almost at the same time. Our youngest child is still small, and my wife keeps...